These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6686971)

  • 1. Sequential histological study of lepromin reaction.
    Desikan KV; Mukherjee A; Ramu G; Tiwari VD
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):473-80. PubMed ID: 6686971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histopathological correlation in the classification of leprosy.
    Bhatia AS; Katoch K; Narayanan RB; Ramu G; Mukherjee A; Lavania RK
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):433-8. PubMed ID: 8228443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune status of subsided cases of tuberculoid (TT) and borderline tuberculoid (BT) leprosy.
    Mackay IG; Sengupta U; Ghei SK; Sinha S; Ramu G
    Lepr India; 1982 Oct; 54(4):653-63. PubMed ID: 6763967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
    Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precipitation of type-I (upgrading) reaction in leprosy by skin testing with antigen and irritants.
    Malhotra B; Das KD; Tutakne MA; Aggarwal SK
    Lepr India; 1983 Apr; 55(2):305-9. PubMed ID: 6632784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-pathological study of lymph node involvement in leprosy.
    Kar HK; Mohanty HC; Mohanty GN; Nayak UP
    Lepr India; 1983 Oct; 55(4):725-38. PubMed ID: 6668933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of clinical, histological and immunological features across the leprosy spectrum.
    Narayan NP; Ramu G; Desikan KV; Vallishayee RS
    Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of clinical and histopathological studies in classification of leprosy.
    Dubey GK; Joglekar VK; Grover S; Chaubey BS
    Lepr India; 1981 Oct; 53(4):562-5. PubMed ID: 7334784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy.
    Singh PK; Ratna ; Jain PK; Mital VP
    Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the reaction to Dharmendra antigen in the normal skin and in the lesion of leprosy patients.
    Price J; Davis M; Ramu G
    Lepr India; 1979 Jan; 51(1):87-95. PubMed ID: 449290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of serum lipids in leprosy.
    Gupta A; Koranne RV; Kaul N
    Indian J Dermatol Venereol Leprol; 2002; 68(5):262-6. PubMed ID: 17656962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histology of the Fernandez reaction. An appraisal.
    Thomas J; Joseph M; Ramanujam K; Chacko CJ; Job CK
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):1-8. PubMed ID: 7195878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lepromin conversion in repeatedly lepromin negative BL/LL patients after immunization with autoclaved Mycobacterium w.
    Chaudhuri S; Fotedar A; Talwar GP
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):159-68. PubMed ID: 6684642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ characterization of cells in the dermal infiltrates of lepromin reaction using monoclonal antibodies.
    Narayanan RB; Ramu G; Malaviya GN; Sengupta U; Desikan KV
    Indian J Lepr; 1985; 57(2):265-72. PubMed ID: 3908574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on the Mitsuda type response to antigens of chemoautotrophic nocardioform bacteria and to standard lepromin in leprosy patients.
    Chakrabarty AN; Dastidar SG; Chandra AK; Mukherjee M; Chaudhuri SK
    Acta Leprol; 1999; 11(3):105-12. PubMed ID: 10544723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunoperoxidase study of immunological factors in skin lesions across the spectrum of leprosy.
    Ridley MJ; Russell DF; Ridley DS
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):11-9. PubMed ID: 7042610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.